<!– –>
Covid-19, a research by the Istituto Superiore di Sanità confirms that type I interferon can block the progression of the disease
A new weapon could arrive from Italy in the fight against Covid-19. Type I interferon (IFN), released by plasmacytoid dendritic cells (pDc) at the beginning of coronavirus infection, appears to elicit an immune response in the body that blocks the progression of the disease. The discovery comes from the joint work of a team of researchers (University of San Raffaele in Milan, Polyclinic of Tor Vergata, University of Padua, Metabolic Fitness Association) coordinated by the Istituto Superiore di Sanita ‘(ISS). The study published in Plos Pathogens analyzes precisely the mechanisms of innate immune responses in the pathogenesis of Covid-19.
Read Also
- Interesting variants and worrying variants of covid-19: what we know May 29, 2021
- Horford enters health protocols and will not play tonight May 19, 2022
- Covid Italia, Rt down to 1.01: the incidence rises Aug 27, 2021
- The passwords of 25 thousand registered to take the medical residency exam were leaked Aug 21, 2021
- How long the coronavirus can survive in the apartment Apr 21, 2020
- Vanessa Saba received the second dose of the vaccine against COVID-19: “Get vaccinated please” Jul 19, 2021
- Seven good reasons to drink milk Jun 2, 2020